Paradigm Therapeutics
Clinical trials sponsored by Paradigm Therapeutics, explained in plain language.
-
New cream aims to safely treat rare skin disease
Disease control Not yet recruitingThis study is testing the safety of a cream called SD-101 for people with epidermolysis bullosa (EB), a condition that causes fragile, blistering skin. About 80 participants who completed a prior study will apply the cream and be monitored for side effects. The goal is to see if …
Phase: PHASE3 • Sponsor: Paradigm Therapeutics • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New cream could speed wound healing for kids with butterfly skin
Disease control Not yet recruitingThis study tests a cream called SD-101 on children aged 1 month to 12 years with epidermolysis bullosa (EB), a condition causing fragile skin and painful blisters. The cream is applied to the whole body to see if it helps close a target wound within one month. About 80 children w…
Phase: PHASE3 • Sponsor: Paradigm Therapeutics • Aim: Disease control
Last updated May 04, 2026 16:23 UTC